BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35876841)

  • 1. Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS.
    Kiesel BF; Parise RA; Krishnamurthy A; Gore S; Beumer JH
    Biomed Chromatogr; 2022 Nov; 36(11):e5455. PubMed ID: 35876841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS/MS assay for the quantitation of the ATR kinase inhibitor VX-970 in human plasma.
    Kiesel BF; Scemama J; Parise RA; Villaruz L; Iffland A; Doyle A; Ivy P; Chu E; Bakkenist CJ; Beumer JH
    J Pharm Biomed Anal; 2017 Nov; 146():244-250. PubMed ID: 28888173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma.
    Kiesel BF; Shogan JC; Rachid M; Parise RA; Vendetti FP; Bakkenist CJ; Beumer JH
    J Pharm Biomed Anal; 2017 May; 138():158-165. PubMed ID: 28213176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of Cabozantinib in Human Plasma by LC-MS/MS.
    Jones R; Holleran J; Parise RA; Rudek MA; Chan J; Wen Y; Gobburu J; Lewis LD; Beumer JH
    J Chromatogr Sci; 2022 Mar; 60(3):274-279. PubMed ID: 34240176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.
    Kiesel BF; Parise RA; Wong A; Keyvanjah K; Jacobs S; Beumer JH
    J Pharm Biomed Anal; 2017 Feb; 134():130-136. PubMed ID: 27907855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice.
    Kiesel BF; Deppas JJ; Guo J; Parise RA; Clump DA; Bakkenist CJ; Beumer JH
    Cancer Chemother Pharmacol; 2022 Jun; 89(6):795-807. PubMed ID: 35507041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
    Holleran JL; Parise RA; Guo J; Kiesel BF; Taylor SE; Ivy SP; Chu E; Beumer JH
    J Pharm Biomed Anal; 2020 Sep; 189():113464. PubMed ID: 32659569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
    Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma.
    Kiesel BF; Parise RA; Tjørnelund J; Christensen MK; Loza E; Tawbi H; Chu E; Kummar S; Beumer JH
    J Pharm Biomed Anal; 2013; 81-82():89-98. PubMed ID: 23644904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
    Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
    Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
    Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma.
    Matsumoto J; Kiesel BF; Parise RA; Guo J; Taylor S; Huang M; Eiseman JL; Ivy SP; Kunos C; Chu E; Beumer JH
    J Pharm Biomed Anal; 2017 Nov; 146():154-160. PubMed ID: 28881312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.
    Lou Y; Qin H; Hu Q; Chai Y; Zhou H; Chen M; Wang Q; Huang P; Gu J; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123394. PubMed ID: 35932695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry.
    Kagan AB; Anders NM; Hemingway A; Lee EQ; Kelly KR; Lee HC; Xu-Welliver M; Piekarz R; Rudek MA
    Biomed Chromatogr; 2022 Nov; 36(11):e5467. PubMed ID: 35895384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers.
    Chen X; Liu G; Wang C; Liu R; Wang M; Huang Y; Shen J; Jia Y
    Biomed Chromatogr; 2023 Aug; 37(8):e5638. PubMed ID: 37002731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
    Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.